BerandaORX • STO
add
Orexo AB
Tutup sebelumnya
kr 25,45
Rentang hari
kr 25,45 - kr 25,90
Rentang tahun
kr 12,50 - kr 43,40
Kapitalisasi pasar
886,86Â jt SEK
Volume Rata-Rata
80,02Â rb
Rasio P/E
-
Hasil dividen
-
Bursa utama
STO
Berita pasar
Keuangan
Laporan Laba Rugi
Pendapatan
Penghasilan bersih
| (SEK) | Sep 2025info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 118,70Â jt | -13,04% |
Biaya operasional | 132,51Â jt | -2,13% |
Penghasilan bersih | -29,80Â jt | 28,88% |
Margin laba bersih | -25,11 | 18,21% |
Penghasilan per saham | — | — |
EBITDA | -9,61Â jt | -580,50% |
Tarif pajak efektif | 8,87% | — |
Neraca
Total aset
Total liabilitas
| (SEK) | Sep 2025info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 105,60Â jt | -8,09% |
Total aset | 518,60Â jt | -25,60% |
Total liabilitas | 742,90Â jt | 2,58% |
Total ekuitas | -224,30 jt | — |
Saham yang beredar | 34,71 jt | — |
Harga terhadap nilai buku | -3,94 | — |
Tingkat pengembalian aset | -9,94% | — |
Tingkat pengembalian modal | -18,48% | — |
Arus Kas
Perubahan kas bersih
| (SEK) | Sep 2025info | Perubahan Y/Y |
|---|---|---|
Penghasilan bersih | -29,80Â jt | 28,88% |
Kas dari operasi | -10,30Â jt | 23,13% |
Kas dari investasi | — | — |
Kas dari pembiayaan | -4,60Â jt | 22,03% |
Perubahan kas bersih | -15,70Â jt | 36,69% |
Arus kas bebas | -8,13Â jt | -166,92% |
Tentang
Orexo is a Swedish pharmaceutical company that develops improved pharmaceuticals based on innovative formulation technologies that meet large medical needs. Through presence its in the US market, drugs and digital therapies are commercialized to treat opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with partners. Wikipedia
Didirikan
1995
Situs
Karyawan
104
